Bristol-Myers Squibb (BMY) Tops Q2 EPS by 43c, Beats on Revenue; Offers FY26 Guidance
Go back to Bristol-Myers Squibb (BMY) Tops Q2 EPS by 43c, Beats on Revenue; Offers FY26 Guidance| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 63.75 +0.14 (0.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.61 | 52 Week High | $77.12 | |||
| Open | $63.49 | 52 Week Low | $49.03 | |||
| Day High | $63.87 | P/E | 41.40 | |||
| Day Low | $63.00 | EPS | $1.54 | |||
| Volume | 1,830,611 | |||||
